In the past week, STTK stock has gone up by 11.16%, with a monthly gain of 9.17% and a quarterly plunge of -1.31%. The volatility ratio for the week is 7.16%, and the volatility levels for the last 30 days are 6.41% for Shattuck Labs Inc The simple moving average for the past 20 days is 8.79% for STTK’s stock, with a 104.31% simple moving average for the past 200 days.
Is It Worth Investing in Shattuck Labs Inc (NASDAQ: STTK) Right Now?
STTK has 36-month beta value of 2.12. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for STTK is 40.75M, and currently, short sellers hold a 4.44% ratio of that float. The average trading volume of STTK on April 11, 2024 was 341.51K shares.
STTK) stock’s latest price update
The stock of Shattuck Labs Inc (NASDAQ: STTK) has increased by 8.44 when compared to last closing price of 9.00.Despite this, the company has seen a gain of 11.16% in its stock price over the last five trading days. Seeking Alpha reported 2023-12-21 that Positive results were released from the phase 1A/B study, using SL-172154 in combination with azacitidine for the treatment of patients with front-line higher-risk myelodysplastic syndrome and TP53 mutant acute myeloid leukemia. Additional results from the phase 1A/B study, using SL-172154 in combination with azacitidine for the treatment of patients with front-line HR-MDS and TP53 mutant AML, expected by mid-2024. The global myelodysplastic syndrome treatment market will reach $5.61 billion by 2032.
Analysts’ Opinion of STTK
Many brokerage firms have already submitted their reports for STTK stocks, with BTIG Research repeating the rating for STTK by listing it as a “Buy.” The predicted price for STTK in the upcoming period, according to BTIG Research is $12 based on the research report published on August 31, 2022 of the previous year 2022.
Citigroup, on the other hand, stated in their research note that they expect to see STTK reach a price target of $13. The rating they have provided for STTK stocks is “Buy” according to the report published on June 01st, 2022.
H.C. Wainwright gave a rating of “Buy” to STTK, setting the target price at $28 in the report published on May 02nd of the previous year.
STTK Trading at 6.51% from the 50-Day Moving Average
After a stumble in the market that brought STTK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.15% of loss for the given period.
Volatility was left at 6.41%, however, over the last 30 days, the volatility rate increased by 7.16%, as shares surge +11.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.31% lower at present.
During the last 5 trading sessions, STTK rose by +11.16%, which changed the moving average for the period of 200-days by +196.66% in comparison to the 20-day moving average, which settled at $9.02. In addition, Shattuck Labs Inc saw 36.89% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STTK starting from Stout Stephen, who sale 16,004 shares at the price of $10.53 back on Mar 06 ’24. After this action, Stout Stephen now owns 74,437 shares of Shattuck Labs Inc, valued at $168,522 using the latest closing price.
Neill Andrew R, the Chief Financial Officer of Shattuck Labs Inc, sale 25,000 shares at $10.00 during a trade that took place back on Jan 10 ’24, which means that Neill Andrew R is holding 173,446 shares at $250,000 based on the most recent closing price.
Stock Fundamentals for STTK
Current profitability levels for the company are sitting at:
- -55.5 for the present operating margin
- -1.54 for the gross margin
The net margin for Shattuck Labs Inc stands at -52.12. The total capital return value is set at -0.62. Equity return is now at value -54.41, with -47.85 for asset returns.
Based on Shattuck Labs Inc (STTK), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -19.33.
Currently, EBITDA for the company is -87.92 million with net debt to EBITDA at 1.38. When we switch over and look at the enterprise to sales, we see a ratio of 206.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 12.51.
Conclusion
To put it simply, Shattuck Labs Inc (STTK) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
